| 14.00 – 16.00 |
Parallel platform sessions 1 – Epilepsy Diagnostics
Room: Auditorium
.
Chair: Alexis Arzimanoglou, France
Co-chair: Joost Nicolai, the Netherlands
- Detection of nocturnal convulsive seizures using an automatically updated heart rate-based algorithm
Thomas de Cooman, Belgium
- “Amplitude-integrated EEG with raw trace” compared with “conventional video EEG” for seizure detection in term neonates: a diagnostic accuracy study
Lakshmi Nagarajan, Australia
- Genetic etiologies screening in Chinese infantile spasms of known cause
Fei Yin, China
- Copy number variation in a hospital-based cohort of children with epilepsy
Danique Vlaskamp, the Netherlands
- Heterozygous truncation mutations of the SMC1A gene cause a severe early-onset epilepsy with cluster seizures in females
Joe Symonds, United Kingdom
- Loss of function mutations in SLC12A5 in autosomal recessive epilepsy of infancy with migrating focal seizures
Amy McTague, United Kingdom
- A combined metabolomic-genetic approach in early onset epileptic encepha-lopathies – towards diagnosis and novel biomarker identification
Barbara Plecko, Switzerland
Parallel platform sessions 2 – Immune-mediated disorders
Room: Forum
Chair: Maarten Titulaer, the Netherlands
Co-chair: Charlotte Haaxma, the Netherlands
- Comparison of Clinical Profile and Short-term outcome of demyelinating and axonal subtypes of Guillain-Barré syndrome (GBS) in children
Naveen Sankhyan, India
- Challenges in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Goknur Haliloglu, Turkey
- Intravenous immunoglubulin in paediatric neurology: safety, efficacy, and adherence to guidelines
Margherita Nosadini, Australia
- Report of autologous hematopoietic stem cell transplantation for pediatric patients with multiple sclerosis: a retrospective multicenter study from the EBMT Autoimmune Diseases Working Party
Kirill Kirgizov, Russia C.I.S.
- Autoimmune encephalitis with temporal lobe pathology, type 1 diabetes mellitus, precocious puberty and GAD antibodies
Melpomeni Giorgi, Greece
- The predictors of long-term Morbidity and Postencephalitic Epilepsy (PE) in Infectious and Autoimmune Encephalitis
Sekhar Pillai, Australia
- Autistic Regression- Immune mediated?
Helly Goez, Canada
Parallel platform sessions 3 – Miscellaneous
Room: Emerald Room
Chair: Michael Shevell, Canada
Co-chair: Judith de Bont, the Netherlands
- Management of Chronic Headaches: obligatory bed-rest
Sinan Çomu, Turkey
- Long term outcomes and risk factors for chemotherapy induced peripheral neuropathy in the paediatric population
Tejaswi Kandula, Australia
- KidsBrainIT: Using information technology to improve childhood brain trauma intensive-care management and patient safety
T. Lo, United Kingdom
- Prevalence of acute seizures and subsequent epilepsy among critically-ill children with acute ischemic stroke
Eric Payne, U.S.A.
- Use of Ocular Coherence Tomography in children with Idiopathic Intracranial Hypertension- A single center experience
Young Ah Lee, U.S.A.
- Hydrocephalus in children less than five years of age: From diagnosis to short/middle/long term evolution
Océane Perdaens, Belgium
- Diagnostic yield and clinical impact of brain biopsy in children presenting with neurological deterioration of unknown cause
Jane Hassell, United Kingdom
Parallel platform sessions 4 – Neurometabolic disorders
Room: E104-E107
Chair: Bwee Tien Poll-The, the Netherlands
Co-chair: Linda de Meirleir, Belgium
- Infantile Tremor Syndrome: An uncommon but treatable cause of neuroregression
Samata Singhi, U.S.A.
- Short- and long-term outcomes of treatment with ketogenic diet in pediatric patients with pyruvate dehydrogenase complex deficiency: The Swedish experience
Kalliopi Sofou, Sweden
- Natural history of CLN2 disease: Quantitative assessment of disease characteristics and rate of progression
Miriam Nickel, Germany
- Intracerebroventricular cerliponase alfa (BMN 190) in children with CLN2 disease: Interim results from a Phase 1/2, open-label, dose-escalation study
Angela Schulz, Germany
- Screening for treatable inborn errors of metabolism in 500 intellectual developmental disorder patients
Clara van Karnebeek, Canada
- Diagnosis and discovery of treatable neurometabolic diseases via an -integrated omics approach
Clara van Karnebeek, Canada
- Genetic defects of thiamine metabolism: a multicenter natural history study
Juan Darío Ortigoza Escobar, Spain
|
